Most Recent
Coffee capsule machine manufacturer Caffitaly has suffered a significant loss in its intellectual property case against a rival, with the Federal Court dismissing its infringement claims and revoking three of its patents in a single shot.
A trade mark infringement lawsuit filed by the former CEO of the Australian Bar Association was not properly brought as a class action on behalf of member barristers, a judge has found.
The Full Federal Court has rejected a patent application for a digital advertising system by e-commerce firm Rokt in a test case by IP Australia that comes as a blow to the patentability of computer software in Australia.
A court has dismissed a claim by the Australian Government for $325 million against pharmaceutical companies Sanofi and Bristol-Myers Squibb allegedly owed for excess subsidies it paid for blood-thinner Plavix as a result of an interlocutory injunction blocking a generic version of the blockbuster drug.
A landmark ruling granting fintech Rokt's application for a software patent has come under attack before the Full Federal Court, with the judges expressing skepticism about the invention's patentability.
A partner at Corrs Chambers Westgarth who successfully opposed a genome editing patent by ToolGen, and a corporate predecessor of law firm Ashurst, have been ordered to pay $375,000 in security in an appeal launched by the South Korean biotech firm.
A former senior Piper Alderman partner who lodged a sex discrimination case against the firm and was forced off the partnership in June is broadening her case, a court has heard.
A former Piper Alderman partner who filed a sex discrimination case against the law firm and was ousted from the partnership months later, is pressing on with her legal action, which was stayed while her complaint to the Australian Human Rights Commission played out.
UK biopharmaceutical company Kymab may attack experiments done by US biotechnology giant Regeneron creating genetically modified mice with splices of human genomes, as it defends its proposed patent for a human rat.
Gaming and entertainment giant Konami has lost a bid to amend its defence in a patent case by rival Aristocrat Technologies on the second day of a damages hearing, with the judge finding the changes were contrary to the interests of justice and would require postponing the trial until late next year.